Genna Reed

Science and policy analyst, Center for Science and Democracy

Author image
Genna Reed is a science and policy analyst in the Center for Science and Democracy at the Union of Concerned Scientists. In her role, she researches political and corporate influences on science-informed decision making—working to inform the public about issues where science is stifled or obscured, and to ensure that federal, state, and local policies are based on rigorous, independent science. See Genna's full bio.

Subscribe to Genna's posts

Genna's Latest Posts

Want to Squash Science? Follow Pruitt’s Lead at the EPA

Just 3 out of 18 executive committee members and 11 out of 49 subcommittee members will remain on a vital EPA science committee, with just 10 days to reapply to their positions. Read more >

Bookmark and Share

Signed, Sealed, Delayed? The New Fate of the Added Sugar Rule and Other Safeguards

The FDA announced this week that it “intends to extend compliance dates” for the nutrition facts label final rules, which will include the separate line for added sugars. We celebrated the finalization of this rule last May as science-based advocacy prevailing to give consumers key information on the foods they consume. While the FDA has not yet announced exactly how long that extension will push back implementation, the food industry has asked HHS Secretary Tom Price to delay the rule’s enforcement three years, until May 2021. Read more >

Bookmark and Share

American Chemistry Council: Obstructing Formaldehyde Safeguards Then and Now

The chemical industry has once again staved off federal action that would protect public health, as the EPA announced last week that it would be delaying compliance dates for the long-awaited formaldehyde emission standards for composite wood products—standards that were finalized in December 2016. This is the latest move brought to you by an industry with a long history of attacking science and an administration willing to do its bidding. Read more >

Bookmark and Share

One of Many Risks of the Regulatory Accountability Act: Flawed Risk Assessment Guidelines

Tomorrow, the Senate will begin marking up Senator Rob Portman’s version of the Regulatory Accountability Act (RAA), which my colleague Yogin wrote a primer about last week. This bill is an attempt to impose excessive burdens on every federal agency to freeze the regulatory process or otherwise tie up important science-based rules in years of judicial review. Read more >

Bookmark and Share

What Does Scott Gottlieb’s Leadership Mean for Scientific Integrity at the FDA?

Later this afternoon the Senate will vote to confirm Scott Gottlieb as the next U.S. Food and Drug Administration (FDA) commissioner. What does this mean for scientists and science-based policymaking at the FDA? His conflicts of interest are certainly an indication that the pharmaceutical industry will benefit more from his tenure than Americans’ health. Read more >

Bookmark and Share